Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CARE-ID is a clinical research organization specializing in the conduct of clinical trials focused on infectious diseases. It has over 30 years of experience evaluating new therapies through scientifically designed studies. Notably, it participated as a site in the BLAZE-1 trial sponsored by Eli Lilly to evaluate monoclonal antibody therapy for COVID-19[4]. The organization collaborates with pharmaceutical companies to test experimental medicines and contributes data that inform treatment guidelines[1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinical Alliance for Research and Education – Infectious Diseases.